18F-Choline PET/CT in Leptomeningeal Breast Cancer MetastasesCuppari, Lea, MD; Reccia, Pasquale, MD; Burei, Marta, MD; Cervino, Anna Rita, MD; Evangelista, Laura, MD, PhDClinical Nuclear Medicine: February 2019 - Volume 44 - Issue 2 - p e96–e97 doi: 10.1097/RLU.0000000000002407 Interesting Images Buy SDC Abstract Author InformationAuthors Article MetricsMetrics We describe a case of 47-year-old woman affected by human epidermal growth factor receptor-2–positive breast cancer with a diffuse leptomeningeal carcinomatosis. An intense uptake of 18F-choline was reported at fused PET/MRI images in the brain, compatible with a diffuse leptomeningeal disease. This case highlights that 18F-choline PET would be used for the identification of leptomeningeal involvement in patients affected by breast cancer, as a support of MRI images. From the Nuclear Medicine and Molecular Imaging Unit, Veneto Institute of Oncology IOV–IRCCS, Padua, Italy. Received for publication July 25, 2018; revision accepted October 21, 2018. Conflicts of interest and sources of funding: none declared. Correspondence to: Laura Evangelista, MD, PhD, Nuclear Medicine and Molecular Imaging Unit, Veneto Institute of Oncology IOV–IRCCS, Via Gattamelata 64, 35128 Padova, Italy. E-mail: email@example.com. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.